Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05129592 · ClinicalTrials.gov registry record · NA

Can Exposure to Brief Messages Correct Misperceptions?

A NA study of Beliefs, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
193
Enrollment target
1
Study location

NCT05129592 is a NA study of Beliefs that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 193 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05129592, a NA study of Beliefs, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
193 participants
Enrollment target
1
Study location

Study Summary

This study seeks to assess the efficacy of educational messages to correct misperceptions. A large proportion of the American population incorrectly believes that nicotine is the chemical responsible for causing cancer in tobacco products.1-3 This misconception may reduce the likelihood that established smokers who are unwilling or unable to quit tobacco product use completely will switch to less harmful non-combustible products. An online experiment will be used to test if corrective messages can reduce this misperception. The experiment will also test the effects of messages on beliefs about the relative harms of other tobacco products discussed in the message and accuracy of inferential beliefs. This will be accomplished by asking participants questions about two tobacco products that are not explicitly discussed in the messages. The experiment will test if the two components of "narrative coherence," a concept identified in previous reviews of misperception correction as effective,4-6 is effective at reducing misperceptions about nicotine. Component 1 provides an explanation for why the new information is correct and component 2 provides an explanation for how the false information came to be believed. This study will use a factorial design to test the efficacy of the component of coherence individually as well as together. Hypotheses and Research Questions: RQ1: Will participants exposed to different corrective message conditions differ in increased accuracy of beliefs (a) that nicotine does not cause cancer, (b) regarding the relative risk of e-cigarettes compared to cigarettes, (c) regarding the relative risk of very low nicotine cigarettes (VLNC) compared to cigarettes and (d) regarding the relative risk of nicotine replacement therapy compared to cigarettes. H1: Participants exposed to the nicotine corrective message with both components of coherence will be significantly more likely to increase accuracy of beliefs regarding the relative harms of (a) smok

Conditions Studied

Interventions

  • BEHAVIORAL Coherent corrective messages

Study Locations (1)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 193 participants
Start Date 2021-11-22
Est. Completion 2022-08-01
Phase NA

What the Registry Record Tells You About NCT05129592

The ClinicalTrials.gov registry entry for NCT05129592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 193 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Beliefs appearing as the primary indexed condition, and to 1 intervention - of which Coherent corrective messages is the first listed.

NCT05129592 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05129592 about?

NCT05129592 is a clinical study titled "Can Exposure to Brief Messages Correct Misperceptions?". This study seeks to assess the efficacy of educational messages to correct misperceptions. A large proportion of the American population incorrectly believes that nicotine is the chemical responsible for causing cancer in tobacco products.1-3 This misconception may reduce the likelihood that establi...

What is the current status of trial NCT05129592?

This trial is currently completed. It is a NA study. The enrollment target is 193 participants. The study started on 2021-11-22. Estimated completion is 2022-08-01.

What conditions does trial NCT05129592 study?

This clinical trial studies the following conditions: Beliefs.

What interventions are being tested in trial NCT05129592?

The interventions under investigation include: Coherent corrective messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT05129592?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05129592 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.